arrow
T

Takayuki Kamikawa

roche holding
H指数:6
被引数:214

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137
2024-10-140
OAAI
Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment
2020-12-0145
OA
Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)

通过基于结构的药物设计 (SBDD) 发现有效且高度选择性的转化生长因子 β 受体相关激酶1 (TAK1) 抑制剂

2016-09-0116
PREAI